Hotspot


Biochimica et Biophysica Acta | 1985

Specific inhibition of polyamine oxidase in vivo is a method for the elucidation of its physiological role

Frank Bolkenius; Philippe Bey; Nikolaus Seiler

N1-Methyl-N2-(2,3-butadienyl)-1,4-butanediamine (MDL 72521) and N1,N2-bis(2,3-butadienyl)-1,4-butanediamine (MDL 72527) are specific, potent, enzyme-activated, irreversible inhibitors of polyamine oxidase in vitro. These compounds are also capable of completely inhibiting polyamine oxidase in mouse tissues at intraperitoneal doses greater than 20 mg/kg. Enzyme activity reappears in the various organs within 2-3 days to 50% of the control values. Irreversible inhibition of polyamine oxidase in mice led to decreased putrescine (30-40%) and spermidine (10-20%) levels in liver and some other organs. At the same time N1-acetylspermidine and, to a lesser extent, N1-acetylspermine were accumulating at rates which are assumed to be related to the rates of polyamine degradation. Even after treatment with polyamine oxidase inhibitors over a period of 6 weeks at doses which produced complete inhibition of polyamine oxidase in all organs, including the brain, neither toxic effects nor changes in body weight or behaviour were observed.


Tetrahedron Letters | 1984

General synthetic access to α-allenyl amines and α-allenyl-α-aminoacids as potential enzyme activated irreversible inhibitors of PLP dependent enzymes

Patrick Casara; Karin Jund; Philippe Bey

Abstract The entitled allene derivatives have been prepared from the parent α-ethynyl amines and α-amino acids. The corresponding derivative of GABA, putrescine and phenylalanine have been found to be irreversible and time dependent inhibitors of GABA-T, ODC and bacterial AADC, respectively.


Biochimica et Biophysica Acta | 1989

The specificity of two proteinases that cleave adjacent to arginine, Cl esterase and acrosin, for peptide p-nitroanilide substrates

Mark T. Skoog; Shujaath Mehdi; Jeffrey S. Wiseman; Philippe Bey

Relative values of Vmax/Km for hydrolysis of 40 peptide p-nitroanilides catalyzed by human Cl-s and human acrosin are reported. For Cl-s, Ac-Lys(gamma Cbz)-Gly-Arg is the optimum sequence, but 25% of the substrates have (Vmax/Km)rel greater than 0.25 compared to this sequence. The best acrosin substrate tested has the sequence Tos-Gly-Pro-Arg, although (Vmax/Km)rel greater than 0.15 for more than half of the substrates. Proline at P2 is preferred by acrosin. Both enzymes prefer arginine at P1 greater than or equal to 3-fold over lysine and will not accept citrulline. In addition, occupancy of site S3 may yield an increase in Vmax/Km of greater than or equal to 10-fold with either enzyme, but many residues are accepted at S2, S3 and S4. Thus, an acrosin assay using Tos-Gly-Pro-Arg p-nitroanilide as a substrate is more than 20-times as sensitive as existing assays with blocked arginine derivatives.


Journal of Medicinal Chemistry | 1985

N-2,3-Butadienyl-1,4-butanediamine derivatives: potent irreversible inactivators of mammalian polyamine oxidase.

Philippe Bey; F.N. Bolkenius; Nikolaus Seiler; Patrick Casara


Archive | 1980

Novel enzyme inhibitors

Philippe Bey; Brian Walter Metcalf; Jeffrey S. Wiseman


Tetrahedron Letters | 1970

Preparation de glycols 2β, 3β a partir d'α - dicetones polycycliques

Philippe Bey; Robert Hanna


Archive | 1980

Dérivés d'aminoacides N-acylés et compositions pharmaceutiques les contenant, intermédiaires et produits de départ

Philippe Bey; Brian Walter Metcalf; Jeffrey S. Wiseman


Tetrahedron Letters | 1978

New approach to the synthesis of a-halogenomethyl-a-amino acids

Philippe Bey


Tetrahedron Letters | 1977

Synthesis of a-alkyl and a-functionalized methyl-a-amino acids

Philippe Bey


Tetrahedron Letters | 1970

Preparation de glycols 2, 3 a partir d'a - dicetones polycycliques

Philippe Bey

Researchain Logo
Decentralizing Knowledge